10 results  1 of 1 

1 Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus
Chi-Ho Lee, Mei-Zhen Wu, David Tak-Wai Lui, Darren Shing-Hei Chan, Carol Ho-Yi Fong, Sammy Wing-Ming Shiu, Ying Wong, Alan Chun-Hong Lee, Joanne King-Yan Lam, Yu-Cho Woo, Karen Siu-Ling Lam, Kelvin Kai-Hang Yiu, Kathryn Choon-Beng Tan
Diabetes Metab J.2022;46(6):843-854.   Published online 2022 April 28     DOI: http://dx.doi.org/10.4093/dmj.2021.0319
      
2 Sitagliptin attenuates endothelial dysfunction independent of its blood glucose controlling effect
Xin-Miao Chang, Fei Xiao, Qi Pan, Xiao-Xia Wang, Li-Xin Guo
Korean J Physiol Pharmacol.2021;25(5):425-437.   Published online 2021 September 1     DOI: http://dx.doi.org/10.4196/kjpp.2021.25.5.425
      
3 Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Hae Kyung Yang, Seung-Hwan Lee, Juyoung Shin, Yoon-Hee Choi, Yu-Bae Ahn, Byung-Wan Lee, Eun Jung Rhee, Kyung Wan Min, Kun-Ho Yoon
Diabetes Metab J.2019;43(3):287-301.   Published online 2018 December 20     DOI: http://dx.doi.org/10.4093/dmj.2018.0054
      
4 Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study
Jaehyun Bae, Min Jung Lee, Eun Yeong Choe, Chang Hee Jung, Hye Jin Wang, Myoung Soo Kim, Yu Seun Kim, Joong-Yeol Park, Eun Seok Kang
Endocrinol Metab.2016;31(1):161-167.   Published online 2016 March 16     DOI: http://dx.doi.org/10.3803/EnM.2016.31.1.161
      
5 Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
Young Ki Lee, Sun Ok Song, Kwang Joon Kim, Yongin Cho, Younjeong Choi, Yujung Yun, Byung-Wan Lee, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee
Diabetes Metab J.2013;37(6):465-474.   Published online 2013 December 12     DOI: http://dx.doi.org/10.4093/dmj.2013.37.6.465
      
6 Factors Influencing Glycemic Control Response of Sitagliptin
Gun Woo Kim, Jae Hyun Kim, Mi Young Lee, Jang Yel Shin, Young Goo Shin, Eun Ho Ha, Choon Hee Chung
J Korean Diabetes.2013;14(4):206-211.   Published online 2013 January 10     DOI: http://dx.doi.org/10.4093/jkd.2013.14.4.206
   
7 Efficacy of Sitagliptin When Added to Ongoing Therapy in Korean Subjects with Type 2 Diabetes Mellitus
Hye Soo Chung, Moon-Kyu Lee
Diabetes Metab J.2011;35(4):411-417.   Published online 2011 August 31     DOI: http://dx.doi.org/10.4093/dmj.2011.35.4.411
      
8 Retrospective Analysis on the Efficacy, Safety and Treatment Failure Group of Sitagliptin for Mean 10-Month Duration
Won Jun Kim, Cheol-Young Park, Eun Haeng Jeong, Jeong Youn Seo, Ji Soo Seol, Se Eun Park, Eun Jung Rhee, Won Young Lee, Ki Won Oh, Sung Woo Park, Sun Woo Kim
Diabetes Metab J.2011;35(3):290-297.   Published online 2011 June 30     DOI: http://dx.doi.org/10.4093/dmj.2011.35.3.290
      
9 Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus
Soon Ae Kim, Woo Ho Shim, Eun Hae Lee, Young Mi Lee, Sun Hee Beom, Eun Sook Kim, Jeong Seon Yoo, Ji Sun Nam, Min Ho Cho, Jong Suk Park, Chul Woo Ahn, Kyung Rae Kim
Diabetes Metab J.2011;35(2):159-165.   Published online 2011 April 30     DOI: http://dx.doi.org/10.4093/dmj.2011.35.2.159
      
10 DPP-4 Inhibitors and the Relations between Rosiglitazone and the Risk of Myocardial Infarction
Hyoung Woo Lee
J Korean Med Assoc.2008;51(4):371-376.   Published online 2008 April 30     DOI: http://dx.doi.org/10.5124/jkma.2008.51.4.371
      

 1 of 1